Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BioNTech SE Sponsored ADR (BNTX) is a stock that can certainly grab the attention of ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading this week, for the April 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BNTX ...

BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

BNTX reported a profit of €12.18 per diluted share in the fourth quarter of 2021, compared with a 4Q 2020 profit of €1.43 per diluted share. BioNTech’s net profit jumped from €15.2m in ...

Check out our BNTX stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.